Fangsheng Pharmaceutical (603998.SH) passed the drug GMP compliance inspection

Zhitongcaijing · 2d ago

Zhitong Finance App News, Fangsheng Pharmaceutical (603998.SH) issued an announcement. Recently, the company received the “Drug GMP Conformity Inspection Notice” issued by the Hunan Drug Administration. The scope of inspection and related workshops and production lines: 1. Ezetimibe, API workshop (101 workshop) B and E zone ezetimib production line; 2. Benidipine hydrochloride, API workshop (workshop 101).